| 11/16/2026 7:00 AM | Abeona Therapeutics (318306) Issuer Charles Faith L. (1853985) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2026 5:58 PM | Abeona Therapeutics (318306) Subject Funicular Funds, LP (1937147) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2026 12:02 PM | Abeona Therapeutics (318306) Subject Kaufman Daniel Louis (2001906) Filed by | Form SCHEDULE 13G/A | |
| 11/09/2026 3:30 PM | Abeona Therapeutics (318306) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 5:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/09/2026 5:35 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/23/2026 1:38 PM | Abeona Therapeutics (318306) Subject James Russell Revocable Trust (2089521) Filed by | Form SCHEDULE 13D | |
| 09/29/2026 8:47 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 8:48 PM | Abeona Therapeutics (318306) Issuer O'Malley Brendan M. (1884342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 8:48 PM | Abeona Therapeutics (318306) Issuer Vazzano Joseph Walter (1715291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 8:48 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ABEO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/29/2026 3:54 PM | Abeona Therapeutics (318306) Subject Vazzano Joseph Walter (1715291) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/29/2026 3:46 PM | Abeona Therapeutics (318306) Subject O'Malley Brendan M. (1884342) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/29/2026 3:47 PM | Abeona Therapeutics (318306) Subject Vasanthavada Madhav (2106295) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/29/2026 3:48 PM | Abeona Therapeutics (318306) Subject Seshadri Vishwas (1865131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 11:00 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/01/2026 4:48 PM | Abeona Therapeutics (318306) Issuer Alvino Mark (1356828) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:05 PM | Abeona Therapeutics (318306) Subject Alvino Mark (1356828) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/22/2026 3:30 PM | Abeona Therapeutics (318306) Issuer Vazzano Joseph Walter (1715291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:30 PM | Abeona Therapeutics (318306) Filer | Form 424B3 | |
| 07/09/2026 6:22 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 6:24 PM | Abeona Therapeutics (318306) Issuer Vazzano Joseph Walter (1715291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 6:17 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 6:20 PM | Abeona Therapeutics (318306) Issuer O'Malley Brendan M. (1884342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:11 PM | Abeona Therapeutics (318306) Subject O'Malley Brendan M. (1884342) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/09/2026 3:12 PM | Abeona Therapeutics (318306) Subject Vazzano Joseph Walter (1715291) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/09/2026 3:15 PM | Abeona Therapeutics (318306) Subject Vasanthavada Madhav (2106295) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/09/2026 3:17 PM | Abeona Therapeutics (318306) Subject Seshadri Vishwas (1865131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 3:33 PM | Abeona Therapeutics (318306) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 06/17/2026 3:30 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 6:48 PM | Abeona Therapeutics (318306) Issuer Silverstein Christine Berni (1772546) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:48 PM | Abeona Therapeutics (318306) Subject Silverstein Christine Berni (1772546) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/12/2026 3:30 PM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/10/2026 3:15 PM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 7:32 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2026 7:32 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2026 7:32 PM | Abeona Therapeutics (318306) Issuer Vazzano Joseph Walter (1715291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2026 7:32 PM | Abeona Therapeutics (318306) Issuer O'Malley Brendan M. (1884342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
What the hell is going on? (Ad) Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway.
The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December.
Watch Porter Stansberry's full broadcast to see which companies could be affected. Watch Porter Stansberry's full broadcast on the coming dollar reset now |
| 06/09/2026 4:24 PM | Abeona Therapeutics (318306) Subject Vazzano Joseph Walter (1715291) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 5:38 PM | Abeona Therapeutics (318306) Subject Vazzano Joseph Walter (1715291) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 5:38 PM | Abeona Therapeutics (318306) Subject Seshadri Vishwas (1865131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 5:39 PM | Abeona Therapeutics (318306) Subject O'Malley Brendan M. (1884342) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 5:40 PM | Abeona Therapeutics (318306) Subject Vasanthavada Madhav (2106295) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/04/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/26/2026 3:30 PM | Abeona Therapeutics (318306) Issuer Alvino Mark (1356828) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 4:24 PM | Abeona Therapeutics (318306) Issuer Alvino Mark (1356828) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:00 PM | Abeona Therapeutics (318306) Issuer Crombez Eric (1653052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 3:44 PM | Abeona Therapeutics (318306) Subject Nantahala Capital Management, LLC (1472322) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 3:32 PM | Abeona Therapeutics (318306) Subject Nantahala Capital Partners Limited Partnership (1502725) Filed by | Form SCHEDULE 13G/A | |
| 05/13/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/13/2026 6:35 AM | Abeona Therapeutics (318306) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/11/2026 5:36 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:16 PM | Abeona Therapeutics (318306) Subject Vasanthavada Madhav (2106295) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/28/2026 3:15 PM | Abeona Therapeutics (318306) Subject HIRSCHMAN ORIN (1131362) Filed by | Form SCHEDULE 13G | |
| 04/27/2026 3:30 PM | Abeona Therapeutics (318306) Filer | Form DEF 14A | |
| 04/27/2026 3:32 PM | Abeona Therapeutics (318306) Filer | Form ARS | |
| 04/17/2026 3:30 PM | Abeona Therapeutics (318306) Filer | Form PRE 14A | |
| 04/07/2026 7:45 AM | Abeona Therapeutics (318306) Issuer Goldan Keith A. (1495411) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/07/2026 7:47 AM | Abeona Therapeutics (318306) Issuer Goldan Keith A. (1495411) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 7:35 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 5:00 PM | Abeona Therapeutics (318306) Subject Funicular Funds, LP (1937147) Filed by | Form SCHEDULE 13G | |
| 03/31/2026 8:03 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:42 PM | Abeona Therapeutics (318306) Subject Seshadri Vishwas (1865131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/27/2026 1:48 PM | Abeona Therapeutics (318306) Subject Kaufman Daniel Louis (2001906) Filed by | Form SCHEDULE 13G | |
| 03/26/2026 8:02 AM | Abeona Therapeutics (318306) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/20/2026 3:30 PM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 6:36 AM | Abeona Therapeutics (318306) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/17/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 6:30 AM | Abeona Therapeutics (318306) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 8:08 AM | Abeona Therapeutics (318306) Subject Adage Capital Management, L.P. (1535978) Filed by | Form SCHEDULE 13G/A | |
| 02/04/2026 3:30 PM | Abeona Therapeutics (318306) Issuer Silverstein Christine Berni (1772546) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 5:59 PM | Abeona Therapeutics (318306) Issuer Wuchterl Donald A. (1857854) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 5:55 PM | Abeona Therapeutics (318306) Issuer Crombez Eric (1653052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:39 PM | Abeona Therapeutics (318306) Subject Alland Leila (1825216) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 3:40 PM | Abeona Therapeutics (318306) Subject Alvino Mark (1356828) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 3:43 PM | Abeona Therapeutics (318306) Subject Crombez Eric (1653052) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/26/2026 3:31 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/26/2026 3:35 PM | Abeona Therapeutics (318306) Issuer Vasanthavada Madhav (2106295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 7:33 PM | Abeona Therapeutics (318306) Issuer O'Malley Brendan M. (1884342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 7:33 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 7:34 PM | Abeona Therapeutics (318306) Issuer Vazzano Joseph Walter (1715291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 3:08 PM | Abeona Therapeutics (318306) Subject Seshadri Vishwas (1865131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:09 PM | Abeona Therapeutics (318306) Subject O'Malley Brendan M. (1884342) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:09 PM | Abeona Therapeutics (318306) Subject Vazzano Joseph Walter (1715291) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:10 PM | Abeona Therapeutics (318306) Subject Vasanthavada Madhav (2106295) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 3:30 PM | Abeona Therapeutics (318306) Issuer Alvino Mark (1356828) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:10 PM | Abeona Therapeutics (318306) Subject Alvino Mark (1356828) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/20/2026 3:30 PM | Abeona Therapeutics (318306) Issuer O'Malley Brendan M. (1884342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
I'm handing you this one free (Ad) Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company.
That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th. See today's free stock pick before the December 8th deadline here |
| 01/20/2026 3:30 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:31 PM | Abeona Therapeutics (318306) Issuer Vazzano Joseph Walter (1715291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:30 PM | Abeona Therapeutics (318306) Issuer Seshadri Vishwas (1865131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |